{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T18:25:25Z","timestamp":1760984725832,"version":"3.44.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","metabolismjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1016\/j.metabol.2012.09.010","type":"journal-article","created":{"date-parts":[[2012,10,22]],"date-time":"2012-10-22T23:07:12Z","timestamp":1350947232000},"page":"492-498","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Normal HDL\u2013apo AI turnover and cholesterol enrichment of HDL subclasses in New Zealand rabbits with partial nephrectomy"],"prefix":"10.1016","volume":"62","author":[{"given":"Paola","family":"Toledo-Ibelles","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martha","family":"Franco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Carre\u00f3n-Torres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G\u00e9rald","family":"Luc","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Tailleux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gilberto","family":"Vargas-Alarc\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Manuel","family":"Fragoso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"Aguilar-Salinas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda","family":"Luna-Luna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oscar","family":"P\u00e9rez-M\u00e9ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.metabol.2012.09.010_bb0005","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/nrcardio.2010.222","article-title":"HDL and cardiovascular disease: atherogenic and atheroprotective mechanisms","volume":"8","author":"Navab","year":"2011","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.metabol.2012.09.010_bb0010","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.bbalip.2011.10.012","article-title":"Predictive value of different HDL particles for the protection against or risk of coronary heart disease","volume":"1821","author":"Rye","year":"2012","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.metabol.2012.09.010_bb0015","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/S0022-2275(20)42753-1","article-title":"Identifying the predominant peak diameter of high-density and low-density lipoproteins by electrophoresis","volume":"31","author":"Williams","year":"1990","journal-title":"J Lipid Res"},{"key":"10.1016\/j.metabol.2012.09.010_bb0020","first-page":"4301","article-title":"Enzymatically active paraoxonase-1 is located at the external membrane of producing cells and released by a high affinity, saturable, desorption mechanism","volume":"277","author":"Deakin","year":"2002","journal-title":"J BiolChem"},{"key":"10.1016\/j.metabol.2012.09.010_bb0025","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1161\/01.ATV.0000091338.93223.E8","article-title":"Small, dense HDL particles exert potent protection of atherogenic LDL against oxidative stress","volume":"23","author":"Kontush","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.metabol.2012.09.010_bb0030","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1053\/meta.2002.31323","article-title":"Chronic hypothyroidism induces abnormal structure of high-density lipoproteins and impaired kinetics of apolipoprotein A-I in the rat","volume":"51","author":"Huesca-G\u00f3mez","year":"2002","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2012.09.010_bb0035","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1194\/jlr.M300422-JLR200","article-title":"Prebeta high density lipoprotein has two metabolic fates in human apolipoprotein A-I transgenic mice","volume":"45","author":"Lee","year":"2004","journal-title":"J Lipid Res"},{"key":"10.1016\/j.metabol.2012.09.010_bb0040","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.atherosclerosis.2004.12.047","article-title":"Pioglitazone increases the fractional catabolic and production rates of high-density lipoproteins apo AI in the New Zealand white rabbit","volume":"181","author":"Carre\u00f3n-Torres","year":"2005","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.metabol.2012.09.010_bb0045","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.cca.2008.11.003","article-title":"Rosiglitazone modifies HDL structure and increases HDL\u2013apo AI synthesis and catabolism","volume":"401","author":"Carre\u00f3n-Torres","year":"2009","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.metabol.2012.09.010_bb0050","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.cca.2006.10.019","article-title":"Palmitic acid reduces the fractional catabolic rates of HDL apo A-I in vivo: contribution of the surface negative charge","volume":"378","author":"P\u00e9rez-M\u00e9ndez","year":"2007","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.metabol.2012.09.010_bb0055","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0021-9150(99)00279-8","article-title":"Metabolism of apolipoproteins A-I and A-II in subjects carrying similar apo A-I mutations, apo A-IMilano and apo A-IParis","volume":"148","author":"P\u00e9rez-M\u00e9ndez","year":"2000","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.metabol.2012.09.010_bb0060","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1097\/01.mol.0000169350.45944.d4","article-title":"The role of the kidney in lipid metabolism","volume":"16","author":"Moestrup","year":"2005","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.metabol.2012.09.010_bb0065","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1681\/ASN.2010111144","article-title":"Uremia alters HDL composition and function","volume":"22","author":"Holzer","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.metabol.2012.09.010_bb0070","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.clinbiochem.2007.10.007","article-title":"The function, composition, and particle size of high-density lipoprotein were severely impaired in an oliguric phase of hemorrhagic fever with renal syndrome patients","volume":"41","author":"Cho","year":"2008","journal-title":"Clin Biochem"},{"key":"10.1016\/j.metabol.2012.09.010_bb0075","doi-asserted-by":"crossref","first-page":"F262","DOI":"10.1152\/ajprenal.00099.2005","article-title":"Dyslipidemia of chronic renal failure: the nature, mechanisms, and potential consequences","volume":"290","author":"Vaziri","year":"2006","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.metabol.2012.09.010_bb0080","doi-asserted-by":"crossref","first-page":"7161","DOI":"10.1016\/S0021-9258(18)32346-9","article-title":"Tissue sites of degradation of apoprotein A-I in the rat","volume":"258","author":"Glass","year":"1983","journal-title":"J Biol Chem"},{"key":"10.1016\/j.metabol.2012.09.010_bb0085","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1194\/jlr.D004358","article-title":"Enzymatic assessment of cholesterol on electrophoresis gels for estimating HDL size distribution and plasma concentrations of HDL subclasses","volume":"51","author":"Toledo-Ibelles","year":"2010","journal-title":"J Lipid Res"},{"key":"10.1016\/j.metabol.2012.09.010_bb0090","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.cca.2010.10.021","article-title":"Lipid plasma concentrations of HDL subclasses determined by enzymatic staining on polyacrylamide electrophoresis gels in children with metabolic syndrome","volume":"412","author":"Garc\u00eda-S\u00e1nchez","year":"2011","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.metabol.2012.09.010_bb0095","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1089\/met.2011.0071","article-title":"The Srb1+1050T allele is associated with metabolic syndrome in children but not with cholesteryl ester plasma concentrations of high-density lipoprotein subclasses","volume":"10","author":"Ju\u00e1rez-Meavepe\u00f1a","year":"2012","journal-title":"Metab Syndr Relat Disord"},{"key":"10.1016\/j.metabol.2012.09.010_bb0100","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/S0022-2275(20)39693-0","article-title":"Immunological properties of apoB-containing lipoprotein particles in human atherosclerotic arteries","volume":"34","author":"Tailleux","year":"1993","journal-title":"J Lipid Res"},{"key":"10.1016\/j.metabol.2012.09.010_bb0105","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1016\/S0022-2275(20)37152-2","article-title":"Clearance of postprandial and lipolytically modified human HDL in rabbits and rats","volume":"38","author":"Lewis","year":"1997","journal-title":"J Lipid Res"},{"key":"10.1016\/j.metabol.2012.09.010_bb0110","doi-asserted-by":"crossref","first-page":"2955","DOI":"10.1161\/01.CIR.0000038303.84249.4A","article-title":"Effect of atorvastatin on high-density lipoprotein apolipoprotein A-I production and clearance in the New Zealand white rabbit","volume":"106","author":"Rashid","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.metabol.2012.09.010_bb0115","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1172\/JCI118614","article-title":"Hyperalphalipoproteinemia in human lecithin cholesterol acyltransferase transgenic rabbits. In vivo apolipoprotein A-I catabolism is delayed in a gene dose-dependent manner","volume":"97","author":"Brousseau","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1016\/j.metabol.2012.09.010_bb0120","doi-asserted-by":"crossref","first-page":"F84","DOI":"10.1152\/ajprenal.00123.2007","article-title":"Renal interstitial adenosine is increased in angiotensin II-induced hypertensive rats","volume":"294","author":"Franco","year":"2008","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.metabol.2012.09.010_bb0125","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/S0022-2275(20)38100-1","article-title":"Characterization of proteoliposomes containing apoprotein A-I.A new substrate for the measurement of lecithin cholesterol acyltransferase activity","volume":"23","author":"Chen","year":"1982","journal-title":"J Lipid Res"},{"key":"10.1016\/j.metabol.2012.09.010_bb0130","doi-asserted-by":"crossref","first-page":"5441","DOI":"10.1021\/bi9919504","article-title":"Role of the kidney in regulating the metabolism of HDL in rabbits: evidence that iodination alters the catabolism of apolipoprotein A-I by the kidney","volume":"39","author":"Braschi","year":"2000","journal-title":"Biochemistry"},{"key":"10.1016\/j.metabol.2012.09.010_bb0135","doi-asserted-by":"crossref","first-page":"4652","DOI":"10.1074\/jbc.M109.069914","article-title":"Structures of discoidal high density lipoproteins: a combined computational\u2013experimental approach","volume":"285","author":"Gu","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1016\/j.metabol.2012.09.010_bb0140","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.ahj.2011.11.017","article-title":"Effect of dalcetrapib plus pravastatin on lipoprotein metabolism and high-density lipoprotein composition and function in dyslipidemic patients: results of a phase IIb dose-ranging study","volume":"163","author":"Ballantyne","year":"2012","journal-title":"Am Heart J"},{"key":"10.1016\/j.metabol.2012.09.010_bb0145","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1172\/JCI116750","article-title":"Delayed catabolism of high-density lipoprotein apolipoproteins A-I and A-II in human cholesteryl ester transfer protein deficiency","volume":"92","author":"Ikewaki","year":"1993","journal-title":"J Clin Invest"},{"key":"10.1016\/j.metabol.2012.09.010_bb0150","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1056\/NEJMoa031766","article-title":"Effects of an inhibitor of cholesteryl ester transfer protein on HDL cholesterol","volume":"350","author":"Brousseau","year":"2004","journal-title":"N Engl J Med"},{"issue":"Suppl 1","key":"10.1016\/j.metabol.2012.09.010_bb0155","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1053\/ajkd.2001.27384","article-title":"Abnormalities in uremic lipoprotein metabolism and its impact on cardiovascular disease","volume":"38","author":"Quaschning","year":"2001","journal-title":"Am J Kidney Dis"}],"container-title":["Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049512003563?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049512003563?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T03:59:42Z","timestamp":1758427182000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026049512003563"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["S0026049512003563"],"URL":"https:\/\/doi.org\/10.1016\/j.metabol.2012.09.010","relation":{},"ISSN":["0026-0495"],"issn-type":[{"type":"print","value":"0026-0495"}],"subject":[],"published":{"date-parts":[[2013,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Normal HDL\u2013apo AI turnover and cholesterol enrichment of HDL subclasses in New Zealand rabbits with partial nephrectomy","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2012.09.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}